Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use Feasibility of the iThermonitor in Pediatric Patients on Myelosuppresive Therapies for Acute Leukemia and Other Childhood Cancers

NCT02410252 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02410252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02410252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use Feasibility of the iThermonitor in Pediatric Patients on Myelosuppresive Therapies for Acute Leukemia and Other Childhood Cancers
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
August 31, 2017
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myeloid leukemia, non-hodgkin lymphoma